Medizinhanf-
Verpackungen

Medizinhanf-Verpackungen

We offer customers a remarkable range of versatile medicinal packaging solutions that respond to the unique needs of the global medicinal cannabis marketplace. We facilitate our customer’s vision to succeed by providing a wide scope; from concept design through to market solutions, supported by extensive global resources.

The Origin Jar, the world’s favourite dried flower jar, is produced in our cleanroom manufacturing facility in the UK. From this starting point, we have broadened our range to cover most primary packaging needs of the medicinal cannabis market.

Origin specialises in medicinal cannabis packaging, ranging from a large amount of stock products which are ready for call-off, to custom packaging, designed and created by our in-house packaging experts. Our team have the knowledge to advise on the correct choice of materials for your packaging to achieve the best results for your target customers.

Manufacturing

Der Reinraum ist folgendermaßen spezifiziert:

  • Klassifikation: ISO7 Klasse 10.000 bis ISO8 Klasse 100.000
  • ISO14644 | ISO9001 konform
  • ISO 15378 | BRC
  • GMP accredited
  • Alle Fertigungsanlagen werden elektrisch angetrieben

Wir verwenden eine Reihe von Fertigungsverfahren vom Streckblasformen bis zum Spritzgießen. In Zusammenarbeit mit Ihnen werden wir die beste Verpackungsoption für Ihr gewünschtes Zielergebnis bestimmen.

Britische Herstellungsanlagen für Medizinhanf-Verpackungen

The Origin Jar is made in our cleanroom manufacturing facilities (GMP accredited), enabling us to create industry-leading packaging, compliant with strict pharmaceutical standards. Origin’s market-leading production environment has a range of production techniques, making it one of the most flexible cleanroom packaging manufacturing facilities in the UK.

Our vast amount of experience in pharmaceutical packaging and devices aligns with the development of new and existing medicinal cannabis products.

Kundenspezifisches Verpackungsdesign

Medizinhanf-Verpackungen

Kindersichere Dosen

Dried cannabis flower packaging

  • Pharmaceutical grade HDPE jars with compatible child resistant closures
  • Nach ISO8317 und 16CFR zertifiziert
  • Auf Bestellung in jeder beliebigen kundenspezifischen Farbe hergestellt

Dried cannabis flower packaging

  • Amber glass jar with compatible child resistant closures
  • Breiter Hals zur leichteren Abgabe
  • Holds up to 10g of dried cannabis flower

Tincture and liquid dose packaging

  • Manipulations- und kindersicherer Pipettenverschluss
  • Choose glass or plastic dropper bottles in different sizes and colours for total delivery system
Oralspritzen 1m - 10 ml Volumen

Tincture and liquid dose packaging

  • Available in four sizes, all with clear graduation marks for easier measurement
  • Child resistant closures available integrated or separate
  • Confirms to BS3221:7 and CE marked

Tincture and liquid dose packaging

  • Compact size with a cosmetic-style aesthetic
  • Range of sizes and neck finishes
  • Certified to 16CFR
  • In einer Reihe von Farben erhältlich

Distillate packaging

  • Amber Type III glass to protect contents from UV light
  • Wide neck for easy access
  • Match with an aluminium closure and pressure sensitive liner for a complete solution

Medizinischer Cannabis (Medizinhanf) hat sich rasch zu einem sehr wirksamen Medikament entwickelt, das positive Auswirkungen auf den menschlichen Körper haben kann.

Cannabis ist eine Pflanze aus der Familie der Hanfgewächse (Cannabaceae) und enthält eine Reihe von biochemischen Inhaltsstoffen. Die Hauptvertreter sind Delta-9-Tetrahydrocannabinol (THC) und Cannabidiol (CBD).

The only cannabis-based product allowed to market and has been approved by the FDA is the drug, Epidiolex, a drug which has been developed to assist people with severe epilepsy. It has been passed as the CBD (not THC) based product is effective for its intended use of supressing seizures.

It is important to understand that THC is a constitute of cannabis and causes the “high”, therefore THC is a potential cause for unknown outcomes for the patient.

Cannabidoid

Einer von mehreren Inhaltsstoffen von Cannabis, auch bekannt als die Marihuana-Pflanze. Zu den Cannabidoiden gehören unter anderem THC und CBD, die unterschiedliche Auswirkungen auf den Körper haben.

THC

Is the major psychoactive component of hemp. THC can be extracted and is used in the FDA approved drug  Dronabinol, which is to help treat nausea associated with cancer medicines. Studies have also found that THC can potentially help improve memory.

CBD

Cannabidiol macht bis zu 40% des Hanf-Extrakts aus. CBD kann oral in flüssiger Form konsumiert oder als Vaporation verabreicht werden. CBD hat andere psychoaktiven Wirkungen als THC. Ein CBD-Medikament für Epilepsie-Erkrankungen wurde von der FDA zugelassen.

Cannabis-basierte medizinische Erzeugnisse

There are a number of cannabis based products being developed for medicinal purposes. One major drug development which has had FDA approval is Epidiolex. The FDA is continually analysing the regulatory frameworks for products that contain cannabis.

Synthetische medizinische Cannabidoide

Synthetische cannabidoidhaltige Medikamente haben eine stärkere Wirkung auf den Körper und können im Vergleich zu ihren natürlichen Pendants schädlich sein. Bei richtiger Entwicklung und sachgerechter Anwendung können synthetische Cannabidioden jedoch den gewünschten therapeutischen Effekt haben.

Nichtmedizinische CBD-Erzeugnisse

Non-medicinal CBD oil comes from industrial hemp. These products have become popular as they don’t create a ‘high’, and may help in reducing inflammation or pain.

Nichtmedizinischer Cannabis

Cannabis, also known as marijuana, is used for recreational purposes and has both creative psychoactive and physiological effects. It is illegal in most countries although recent years have see some countries and USA federal states legalise it.

Nichtmedizinische synthetische Cannabidoide

Werden speziell hergestellt und nicht direkt aus der Hanfpflanze gewonnen. Diese "Designer"-Drogen wurden entwickelt, um rechtliche Beschränkungen in bestimmten Ländern zu umgehen.

Origin is involved with a number of major medical cannabis-based products and is strategically placed across Europe, North America and Australasia to support new projects which are in early stage development. With our packaging knowledge and supply chain model we enable your product to go from development to commercial in record speeds.

Don't miss a thing from Origin.

Fill in your details below to be added to our mailing list.

×